Abstract
This study investigated three physiologic functions known to be modulated by serotonin — temperature, food intake and locomotor activity — using the 5-HT3 receptor agonist,m-chlorophenylbiguanide (m-CPBG), and two 5-HT3 antagonists, MDL-72222 and ondansetron. m-CPBG produced dose-dependent elevations in rectal temperature. MDL-72222, which had no effects on temperature when given alone, significantly attenuated m-CPBG-induced hyperthermia. Food intake in food-deprived rats was reduced during the first hour by the highest dose of m-CPBG. Food intake was also dose-dependently reduced by MDL-72222; m-CPBG plus MDL-72222 led to greater reductions in food intake. Food intake in freely fed rats was unaffected by m-CPBG or MDL-72222. Locomotor activity was unaffected by m-CPBG, but was dose-dependently reduced by MDL-72222, an effect which may have contributed to its hypophagic effects. Ondansetron, used in ten-fold lower doses than MDL-72222, was inactive in all of these paradigms. These data: (1) provide some evidence for 5-HT3 receptor-mediated changes in temperature; (2) are in agreement with two prior studies which reported locomotor activity reductions following 5-HT3 antagonists; but (3) do not support an important role for 5-HT3 receptors in the regulation of food intake in rats.
Similar content being viewed by others
References
Adrien J, Tissier MH, Lanfumey L, Haj DS, Jolas T, Franc B, Hamon M (1992) Central action of 5-HT3 receptor ligands in the regulation of sleep-wakefulness and raphe neuronal activity in the rat. Neuropharmacology 31[6]: 519–529
Alper RH (1990) Evidence for central and peripheral serotonergic control of corticosterone secretion in the conscious rat. Neuroendocrinology 51: 255–260
Aulakh CS, Hill JL, Murphy DL (1989) A comparison of feeding and locomotion responses to serotonin agonists in three rat strains. Pharmacol Biochem Behav 31: 567–571
Aulakh CS, Hill JL, Murphy DL (1992) Effects of various serotonin receptor subtype selective antagonists alone and on m-CPP-induced neuroendocrine changes in rats. J Pharmacol Exp Ther 263: 588–595
Aulakh CS, Mazzola-Pomietto P, Wozniak K, Hill J, Murphy DL (1994) Evidence that 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM)-induced hypophagia and hyperthermia in rats is mediated by 5-HT2A receptors. J Pharmacol Exp Ther 270: 127–132
Bagdy G, Calogero AE, Murphy DL, Szemeredi K (1989) Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. Endocrinology 125: 2664–2669
Barnes JM, Barnes NM, Costall B, Naylor RJ, Tyers MB (1989) 5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue. Nature 338: 762–763
Blandina P, Goldfarb J, Green JP (1988) Activation of a 5-HT3 receptor releases dopamine from rat striatal slice. Eur J Pharmacol 155[3]: 349–350
Butler A, Hill JM, Ireland SJ, Jordan CC, Tyers MB (1988) Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors. Br J Pharmacol 94: 397–412
Calogero AE, Bagdy G, Szemeredi K, Tartaglia ME, Gold PW, Chrousos GP (1990) Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology 126: 1888–1894
Chen JP, van Praag HM, Gardner EL (1991) Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res 543[2]: 354–357
Costall B, Domeney AM, Naylor RJ, Tyers MB (1987) Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain. Br J Pharmacol 92: 881–894
Dourish CT, Hutson PH, Curzon G (1985) Low doses of the putative serotonin agonst 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology 86: 197–204
Fozard JR (1984) MDL-72222, a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedebergs Arch Pharmacol 326: 36–44
Fozard JR (1990) Agonists and antagonists of 5-HT3 receptors. In: Saxena PR, Wallis DI, Wouters W, Bevan P (ed) Cardiovascular pharmacology of 5-hydroxytryptamine. Kluwer Academic Publishers, Boston, pp 101–115
Fuller RW (1990) Serotonin receptors and neuroendocrine responses. Neuropsychopharmacology 3: 495–502
Galzin AM, PoncetV, Langer SZ (1990) 5-HT3 receptor agonists enhance the electrically evoked release of 5-HT in guinea pig frontal cortex slices. Br J Pharmacol 100: 307P
Gartside SE, Cowen PJ (1990) Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptors. Eur J Pharmacol 179: 103–109
Gilbert F, Brazell C, Tricklebank MD, Stahl SM (1988) Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration. Eur J Pharmacol 147: 431–439
Hagan RM, Jones BJ, Jordan CC (1990) Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat. Br J Pharmacol 99: 227–232
Hardy JD (1961) Physiology of temperature. Physiol Rev 41: 521–606
Higgins GA, Joharchi N, Sellers EM (1993) Behavioral effects of the 5-hydroxytryptamine3 receptor agonists 1-phenylbiguanide andm-chlorophenylbiguanide in rats. J Pharmacol Exp Ther 264[3]: 1440–1449
Hoyer D, Neijt HC (1988) Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding. Mol Pharmacol 33: 303–309
Humphrey PPA, Hartig P, Hoyer D (1993) A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci 14: 233–236
Imperato A, Angelucci L (1989) 5-HT3 receptors control dopamine release in the nucleus accumbens of freely moving rats. Neurosci Lett 101: 214–217
Kennett GA, Curzon G (1988) Evidence that m-CPP may have behavioral effects mediated by central 5-HT1C receptors. Br J Pharmacol 94: 137–147
Kennett GA, Curzon G (1991) Potencies of antagonists indicate that 5-HT1C receptors mediate 1–3(chlorophenyl)piperazine-induced hypophagia. Br J Pharmacol 103: 2016–2020
Kilpatrick GJ, Jones BJ, Tyers MB (1987) Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature 330: 746–748
Kilpatrick GJ, Butler A, Burridge J, Oxford AW (1990) 1-(m-Chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist. Eur J Pharmacol 1990: 193–197
Koenig JI, Gudelsky GA, Meltzer HY (1987) Stimulation of corticosterone and b-endorphin secretion in the rat by selective 5-HT receptor subtype activation. Eur J Pharmacol 137: 1–8
Laporte AM, Koscielniak T, Ponchant M, Verge D, Hamon M, Golzan H (1992) Quantitative autoradiographic mapping of 5-HT3 receptors in the rat CNS using [125I]iodo-zacopride and [3H]zacopride as radioligands. Synapse 10: 271–281
Martin KF, Hannon S, Phillips I, Heal DJ (1992) Opposing roles for 5-HT1B and 5-HT3 receptors in the control of 5-HT release in the hippocampus in vivo. Br J Pharmacol 106: 139–142
Matthes H, Boschert U, Amlaiky N, Grailhe R, Plassat JL, Muscatelli F, Mattei MG, Hen R (1993) Mouse 5-hydroxytryptamine 5A and 5-hydroxytryptamine 5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization. Mol Pharmacol 43: 313–319
Mazzola-Pomietto P, Aulakh CS, Wozniak KM, Johnson D, Murphy DL (1993) Evidence that m-CPP-induced hyperthermia in rats is mediated by 5-HT1C receptors. Soc Neurosci Abstr 19: 1380
Mazzola-Pomietto P, Aulakh CS, Wozniak KM, Hill JL, Murphy DL (1995) Evidence that 1-(2,5-di-methoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors. Psychopharmacology 117: 193–199
Meyerson LR, Park Y (1991) Unusual binding of [3H] MDL 72222 in guinea pig hippocampus. Drug Dev Res 23: 27–33
Monsma FJ, Shen Y, Ward RP, Hamblin MW, Sibley DR (1993) Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol 43: 320–327
Moser PC (1990) Inhibition of nicotine-induced hyperactivity by 5-HT3 receptor antagonists. Eur J Pharmacol 183: 1950
Mulroney SE, Skudlarek C, Shemer A, Lumpkin MD, Kellar KJ (1994) Tandospirone stimulates prolactin secretion in the rat by an action at serotonin-1A receptors. J Pharmacol Exp Ther 268[2]: 862–7
Pranzatelli MR (1990) Evidence for involvement of 5-HT2 and 5-HT1C receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenyl)-2- aminopropane (DOI). Neurosci Lett 115: 74–80
Reith MEA (1990) 5-HT3 receptor antagonists attenuate cocaine-induced locomotion in mice. Eur J Pharmacol 186: 327–330
Schechter LE, Simansky KJ (1988) 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI) exerts an anorexic action that is blocked by 5-HT2 antagonists in rats. Psychopharmacology 94: 342–346
Shen Y, Monsma FJJ, Metcalf MA, Jose PA, Hamblin MW, Sibley DR (1993) Molecular cloning and expression of a 5-hydroxy-tryptamine7 serotonin receptor subtype. J Biol Chem 268: 18200–18204
Tecott LH, Maricq AV, Julius D (1993) Nervous system distribution of the serotonin 5-HT3 receptor mRNA. Proc Natl Acad Sci USA 90: 1430–1434
Togashi H, Matsumoto M, Yoshioka M, Saito H (1992) Behavioral characterization of 5-HT3 receptor antagonist, ondansetron, in rats. Biogenic Amines 9: 15–27
Van der Hoek GA, Cooper SJ (1994) Ondansetron, a selective 5-HT3 receptor antagonist, reduces palatable food consumption in the nondeprived rat. Neuropharmacology 33: 805–811
Wang P, Aulakh CS, Hill JL, Murphy DL (1988) Fawn-Hooded rats are subsensitive to the food intake suppressant effects of 5-HT agonists. Psychopharmacology 94: 558–562
Wozniak KM, Aulakh CS, Hill JL, Murphy DL (1988) The effect of 8-OH-DPAT on temperature in the rat and its modification by chronic antidepressant treatments. Pharmacol Biochem Behav 30: 451–456
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mazzola-Pomietto, P., Aulakh, C.S. & Murphy, D.L. Temperature, food intake, and locomotor activity effects of a 5-HT3 receptor agonist and two 5-HT3 receptor antagonists in rats. Psychopharmacology 121, 488–493 (1995). https://doi.org/10.1007/BF02246499
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246499